No Detail Found!

MicroRNA Profiling in High-Risk Pregnancy: A Multicentric Cross-Sectional Study on Early and Late-Onset Preeclampsia

Author(s)
Vinaya Vijayan Department of Physiology, Saveetha Institute of Medical and Technical Sciences, Chennai, India
R. Kannan Department of General Medicine, Saveetha Medical College, Chennai, India
Y. Subhashini Fernandez Hospitals Hyderabad, Telangana, India
Aparajita D'souza Department of Obstetrics and Gynaecology, ESIC Medical College, Hyderabad, Telangana, India
S. Tarakeswari Fernandez Hospitals Hyderabad, Telangana, India
B. Ram Reddy Department of Physiology, Apollo Institute of Medical Sciences and Research, Hyderabad, Telangana, India
Suyash Agarwal Fernandez Hospitals Hyderabad, Telangana, India
Banala Rajkiran Reddy Fernandez Hospitals Hyderabad, Telangana, India
Abstract
Background: Preeclampsia (PE) is a hypertensive disorder of pregnancy associated with maternal and fetal complications. Current diagnostic methods rely on clinical symptoms, often leading to late detection. MicroRNAs (miRNAs) are promising molecular biomarkers for early PE identification due to their regulatory role in placental development and maternal vascular adaptation. Objective: This study aimed to identify differentially expressed miRNAs in early-onset (EOPE) and late-onset (LOPE) PE, comparing their profiles with normal pregnancies to evaluate their potential as diagnostic biomarkers. Methods: A multicentric cross-sectional study was conducted across hospitals in South India. Thirteen participants were enrolled, including five EOPE, five LOPE and three normotensive pregnancies. Placental and plasma miRNA profiles were analyzed using nextgeneration sequencing (NGS). Bioinformatics analysis identified significantly dysregulated miRNAs. Statistical validation included differential expression analysis, confidence intervals and effect size calculations. Results: Peripheral blood profiling in EOPE showed upregulation of miR-532-5p, miR-1285-5p, miR-6515-5p and miR-548ae-5p, while miR-4732-5p was downregulated. In LOPE, miR-532-5p, miR-6b-3p, miR-6734-5p and miR-146b-5p were significantly upregulated, while miR3127-5p, miR-5695, miR-202-5p and miR-185-5p were downregulated. Placental profiling revealed distinct miRNA expression patterns, including upregulated miR-508-3p and miR-1246 in EOPE and downregulated miR-34b-5p in LOPE. Conclusion: This study highlights specific miRNA signatures associated with PE, providing a basis for early non-invasive screening. Findings align with previous studies demonstrating miRNA-based PE detection with high sensitivity and specificity. The existing literature lacks an in vivo study based on microRNA profiling using the NGS method in preeclampsia. Larger cohort studies are needed for external validation and clinical translation of miRNA-based diagnostics.
Publication Details
Page(s) 81-87
Published Journal: Journal of Pioneering Medical Sciences, Volume: 14, Issue: 5, Year: 2025

Request the full text from PASTIC

Keywords
Next-generation sequencing, Preeclampsia, MicroRNA, Biomarkers, late-onset PE (LOPE), early-onset PE (EOPE)
References
Mlambo Zinhle P.,November Zinhle P. .2024 .Immunoexpression of placental growth factor (PlGF) and soluble FMS-like tyrosine kinase 1 (sFlt-1) in the placental bed of preeclamptic women of African ancestry living with HIV infection. ” Histochemistry and Cell Biology, 163(1) : .
Giannubilo Stefano,Raffaele Stefano,January Stefano .2024 .Circulating miRNAs and preeclampsia: from implantation to epigenetics. International Journal of Molecular Sciences, 25(3) : .
Fasoulakis .2023 .MicroRnas in preeclampsia. Expert review of molecular diagnostics.”, 2284780(12) : 1053-1055.
Mathew . .Prevalence of hypertensive disorders of pregnancy, associated factors and pregnancy complications in a primigravida population. ” Gynecology and Obstetrics Clinical Medicine, 3(2) : 119-123.
Sun .2022 .Association between maternal family history of hypertension and preterm birth: modification by noise exposure and multivitamin intake. The Journal of MaternalFetal & Neonatal Medicine, 2128665(26) : 10458-10465.
Shandilya . ./preeclampsia-prevalence-riskfactors-and-impact-on-mother-and-fetus/.. Indian Journal of Cardiovascular Disease in Women, 8(3) : 193-199.
Winger Edward E.,January Edward E. .2018 .Peripheral blood cell microRNA quantification during the first trimester predicts preeclampsia: Proof of concept. PLoS One, 0190654(1) : .
Ma .2021 .Bioinformatic analysis and validation of microRNA‐508‐3p as a protective predictor by targeting NR4A3/MEK axis in pulmonary arterial hypertension. ” Journal of Cellular and Molecular Medicine, 25(11) : 5202-5219.
Socha ,January .2021 .The role of NF-κB in uterine spiral arteries remodeling, insight into the cornerstone of preeclampsia. International Journal of Molecular Sciences, 22(2) : .
Haider .2022 .Transforming growth factor-β signaling governs the differentiation program of extravillous trophoblasts in the developing human placenta. ” Proceedings of the National Academy of Sciences, 119(28) : .
Xu .2018 .ANXA4 promotes trophoblast invasion via the PI3K/Akt/eNOS pathway in preeclampsia. American Journal of Physiology-Cell Physiology, 316(4) : C481-C491.
Timofeeva Angelika V.,April Angelika V. .2023 .Prediction of early-and lateonset pre-eclampsia in the preclinical stage via placentaspecific extracellular miRNA profiling. International Journal of Molecular Sciences, 24(9) : .
Hu ,April 2019 . .MicroRNA-144-3p may participate in the pathogenesis of preeclampsia by targeting Cox-2. , 19(6) : 4655-4662.
Ives .2020 .Preeclampsia-pathophysiology and clinical presentations: JACC state-of-the-art review. ” Journal of the American College of Cardiology, 08(14) : 1690-1702.
Luo . .Identification of key microRNAs and genes in preeclampsia by bioinformatics analysis. PLoS One, 0178549(6) : .
Addo . .Placental microRNAs: Responders to environmental chemicals and mediators of pathophysiology of the human placenta. ” Toxicology Reports, 7(2020) : 1046-1056.
0

Citations

0

Downloads

30

Views